Medication info
Rinahana Tablets (Linagliptin)

Rinahana Tablets (Linagliptin)

Prescription medicationTablet
Ingredient · strength
Linagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
(주)에이프로젠바이오로직스
Appearance
Pink round film-coated tablets
Packaging
28 tablets/PTP [14 tablets/PTP*2], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202303418 · Approved 2023.12.22 · Insurance code 645210870

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who uses it
Adults
Adult dosage
The recommended dose for this medication is 5 mg once daily. It can be taken regardless of meals.

Ingredients

Manufacturer
(주)에이프로젠바이오로직스

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

View approved original text

This medication is used as an adjunct to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination with other medications, along with dietary and exercise regimens. This contributes to effective control of blood sugar levels and helps improve diabetes management.

Dosage and Administration

Adult dosage

The recommended dose for this medication is 5 mg once daily. It can be taken regardless of meals.

Precautions

This medication should not be used in patients with allergies to the active ingredient or other components. It is not safe for patients with type 1 diabetes or diabetic ketoacidosis. Patients with a history of myocardial infarction or those who have had a myocardial infarction are also advised against using this medication. When used with other medications that may cause hypoglycemia, especially insulin or sulfonylurea drugs, there may be an increased risk of hypoglycemia, so caution is advised. Experience with this medication in heart failure patients is limited, so it should be used carefully. Acute pancreatitis may occur during treatment with this medication; therefore, if severe abdominal pain persists, treatment should be stopped immediately and a consultation with a physician is required. Skin conditions such as bullous pemphigoid may occur; therefore, if blisters or skin erosion develop, medical personnel should be informed immediately. Various adverse reactions, including hypoglycemia, have been reported with this medication, so if any abnormal symptoms appear during treatment, a physician should be consulted immediately. Severe joint pain may occur; therefore, if joint pain worsens, intake of this medication should be stopped and a professional should be consulted. Use of this medication is not recommended for those who are pregnant or breastfeeding, and nursing mothers should be cautious as this medication may be excreted in breast milk. Safety and efficacy in children under 10 years old and adolescents aged 10 to 17 have not been sufficiently established, so the use of this medication is not recommended. Elderly patients can use this medication without specific dose adjustments, and it can also be administered without dose adjustments in patients with impaired kidney or liver function. In the case of overdose, there is no specific antidote, so general supportive treatment such as the removal of incompletely absorbed substances from the gastrointestinal tract and monitoring of symptoms should be implemented. This medication should be kept out of reach of children, and transferring it to another container can lead to accidents or quality degradation, so caution is advised.

Side effects and when to seek care immediately

Serious side effects

  • Hives
  • angioedema
  • pancreatitis
  • bullous pemphigoid
  • chest tightness
  • difficulty breathing
  • fever
  • severe allergic reactions
  • severe skin adverse reactions
  • liver abnormalities (jaundice)
Show 13 more
  • sudden and severe headache
  • thunderclap headache
  • seizures
  • confusion
  • visual disturbances
  • paralysis
  • significantly reduced urine output
  • severe swelling of the body
  • increased blood pressure
  • severe and debilitating joint pain
  • congestive heart failure
  • angina
  • acute myocardial infarction

Mild side effects

  • Hypoglycemia
  • hypertriglyceridemia
  • hyperlipidemia
  • cough
  • constipation
  • oral ulcers
  • rash
  • weight gain
  • increased lipase
  • increased amylase
Show 24 more
  • dyspepsia
  • edema
  • facial swelling
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • decreased appetite
  • cerebral infarction
  • dysarthria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it is best to avoid extremely hot or cold places and to store it at room temperature, between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

28 tablets/PTP [14 tablets/PTP*2], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.